title: The current status of ponatinib in the treatment of chronic myeloid leukemia.
authors.affiliation: University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah.
authors.forename: Michael
authors.initials: M
authors.lastname: Deininger
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D011724:Pyridazines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D011724:Pyridazines; C545373:ponatinib